FAQ

UDP Glucuronosyltransferases Inhibitors [MoA]

Known as: UDP Glucuronosyltransferases (UGT) Inhibitors, UDP Glucuronosyltransferases Inhibitors, UGT Inhibitors 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2017
0119942017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Data Generated by Quantitative Liquid Chromatography-Mass Spectrometry Proteomics Are Only the Start and Not the Endpoint: Optimization of Quantitative Concatemer-Based Measurement of Hepatic Uridine…
Quantitative proteomic methods require optimization at several stages, including sample preparation, liquid chromatography-tandem… (More)
Is this relevant?
Review
2017
Review
2017
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?
Bladder cancer has been linked to numerous toxins which can be concentrated in the bladder after being absorbed into the blood… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups.
Previous studies demonstrated that perinatal exposure to polybrominated diphenyl ethers (PBDEs), a major class of brominated… (More)
Is this relevant?
1994
1994
Use of cloned and expressed human liver UDP-glucuronosyltransferases for analysis of drug glucuronide formation and assessment of drug toxicity.
Five cloned human hepatic UDP-glucuronosyltransferase (UGT) cDNAs were stably expressed in tissue culture cell lines. More than… (More)
  • table 1
  • figure 1
Is this relevant?